Docetaxel as neo-adjuvant therapy for radically treatable stage III non-small cell lung cancer : early results of an international phase III study
Finna-arvio
Docetaxel as neo-adjuvant therapy for radically treatable stage III non-small cell lung cancer : early results of an international phase III study
Tallennettuna:
Kieli |
englanti |
---|